Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Netherlands

European Research Council grant · Running

ContiZymes Continuous Enzyme Evolution – solving bottlenecks in enzyme engineering to design next-generation biocatalysts

Coordinator
Rijksuniversiteit Groningen, Netherlands
Runs
1 May 2024 to 30 April 2029
Status
Running
EU funding
€2.0m
Total cost
€2.0m
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101125957

What the project is doing

In the project's own words, from its summary on CORDIS.

Directed evolution has revolutionized the application of enzymes in industrial settings by allowing users to tailor the properties and activities of biocatalysts to their needs. But classic directed evolution is notoriously labor- and time-intensive, as it manually stages mutation, selection, and amplification cycles. In contrast, continuous evolution (CE) approaches aim to achieve these steps within a replicating organism, making it possible to engineer efficient enzymes in a matter of days rather than months or years.

Unfortunately, current CE approaches are typically applicable only to model enzymes with little industrial value. To unleash the full potential of CE, we will develop a scalable, low-tech CE platform, which is readily applicable to biocatalysts that provide value-added products. Toward this end, we will merge a versatile selection system we recently developed with strategies to diversify the genes of targeted enzymes in vivo and an autonomous setup to grow bacterial populations continuously.

Combined the resulting CE-platform will enable us to engineer biocatalysts along many and long evolutionary trajectories. Moreover, analyzing the fate of these populations by sequencing will allow us to map the sequence-structure-function relationships of these biocatalysts. Based on the systematic datasets generated in these efforts, we will train machine-learning (ML)-models to predict functional sequences. Lastly, in a ML-directed CE approach, we will establish a design-build-test-learn cycle to improve models and guide CEs toward promising, but otherwise inaccessible sequence spaces.

Overall, ContiZymes will overcome unaddressed challenges associated with the application of biocatalysts that promote sought-after C-C, C-halogen, and C-N-bond forming reactions. We will not only engineer these enzymes at an unprecedented rate and scale, but also map their fitness landscapes and take a critical step toward the on-demand design of next-generation biocatalyst

Topics

Who is involved

OrganisationCityCountryRole
Rijksuniversiteit GroningenGroningenNetherlandsCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI